SC 13G Filing

Company

Aclaris Therapeutics, Inc.

Filed

February 1, 2018

Accession Number

0000215457-18-004610

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →